Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Max Hospital, Gurgaon offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2007, the ISO, NABH, NABL accredited hospital is located in Gurgaon, India and has 104 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
At Sikarin Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 1979, this JCI accredited hospital in Bangkok, Thailand has 354 beds and offers advanced interventional and congenital cardiology services.
Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.
Indraprastha Apollo Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 1996, the JCI accredited hospital is located in Delhi, India and operates 710 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
Choosing Apollo Hospitals for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1988, the JCI accredited hospital in Hyderabad, India has 550 beds and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
Star Hospitals is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2008, the NABH, NABL- accredited hospital is situated in Hyderabad, India and has 435 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
At Sterling Wockhardt Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2001, this NABL accredited hospital in Mumbai, India has 225 beds and offers advanced interventional and congenital cardiology services.
Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.
Delhi, India
Max Super Speciality Hospital, Patparganj offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2005, the NABH, NABL, AACI accredited hospital is located in Delhi, India and has 400 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Choosing Centro Medico Teknon for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1994, the JCI accredited hospital in Barcelona, Spain has 211 beds and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
Hospital Quironsalud Barcelona offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 1944, the JCI, ISO accredited hospital is located in Barcelona, Spain and has 165 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Choosing The London Clinic for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in , the JCI accredited hospital in London, United Kingdom has 234 beds and provides specialized congenital heart disease services.
Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.
Farrer Park Hospital offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2016, the accredited hospital is located in Singapore, Singapore and has 220 beds, providing comprehensive cardiac care for local and international patients.
Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.
Venkateshwar Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2016, the NABL, NABH- accredited hospital is situated in Delhi, India and has 325 beds.
Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.
Medical Park Trabzon Star Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2011, the JCI accredited hospital is located in Trabzon, Turkey and operates 120 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
At Medical Park Usak Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2013, this JCI accredited hospital in Usak, Turkey has 106 beds and offers advanced interventional and congenital cardiology services.
Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.
Medical Park Tokat Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2015, the JCI accredited hospital is located in Tokat, Turkey and operates 157 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.
Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.
| Speciality | Cardiac Sciences |
| Procedure | Device Closure of ASD (Amplatzer Septal Occluder) |
| Success Rate | 95-98% |
| Recovery Time | 1 to 2 days |
| Treatment Time | 2 to 3 hours |
| Chances of Recurrence | 1-2% |
An atrial septal defect is an opening in the wall of the heart that can cause mixing of the blood between the heart’s upper chambers, called atria. This is a minimally invasive procedure that involves inserting a special device, called the Amplatzer Septal Occluder, through a catheter into the heart. The device is positioned to cover the ASD, allowing the tissue to grow over it, effectively sealing the hole.
The ASD device closure procedure is primarily used to treat Atrial Septal Defects, which are congenital heart conditions present at birth. It is suitable for certain patients who have smaller atrial septal openings or less serious conditions that can be corrected without open-heart surgery. An experienced cardiac surgeon will diagnose the type of ASD and then suggest the Amplatzer Septal Occluder-based procedure.
After the atrial septal defect closure, patients typically spend a short time in the hospital for observation. The recovery process is relatively quick, with minimal pain and scarring. Most patients can resume their normal activities within a few days to a week, but strenuous activities may be restricted for a few weeks after the surgery. Regular follow-up visits with the cardiologist are recommended to check the progress and ensure the effectiveness of the device after ASD closure is performed.
